Definition of glaucoma: Clinical and experimental concepts

Clinical and Experimental Ophthalmology

Volumn 40, Issue 4, 2012, Pages 341-349

  Casson, Robert J ^a   Chidlow, Glyn ^a   Wood, John P M ^a   Crowston, Jonathan G ^b   Goldberg, Ivan ^c  

^a HANSON INSTITUTE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c SYDNEY EYE HOSPITAL   (Australia)

Author keywords

Glaucoma; Glaucomatous field defect; Optic nerve

Indexed keywords

CLINICAL FEATURE; CLOSED ANGLE GLAUCOMA; DISEASE CLASSIFICATION; DISEASE COURSE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GLAUCOMA; HUMAN; INTRAOCULAR HYPERTENSION; MEDICAL HISTORY; NEUROPATHY; OPEN ANGLE GLAUCOMA; OPTIC NERVE; OPTIC NERVE DISEASE; PATHOGENESIS; PRIMARY ANGLE CLOSURE GLAUCOMA; RETINA GANGLION CELL; REVIEW; SECONDARY ANGLE CLOSURE GLAUCOMA; SECONDARY GLAUCOMA;

ANIMALS; DISEASE MODELS, ANIMAL; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; OPTIC NERVE DISEASES; TERMINOLOGY AS TOPIC;

EID: 84862523794     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2012.02773.x     Document Type: Review

References (65)

1. Dandona L, Dandona R. What is the global burden of visual impairment? BMC Med 2006; 4: 6.
2. Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol 1996; 80: 389-93.
3. Bathija R, Gupta N, Zangwill L, Weinreb RN. Changing definition of glaucoma. J Glaucoma 1998; 7: 165-9.
4. American Academy of Ophthalmology Glaucoma Panel. Preferred Practice Pattern® Guidelines. Primary Open-Angle Glaucoma. San Francisco, CA: American Academy of Ophthalmology, 2010. Accessed 12/1/12. Available at:
5. Foster PJ, Buhrmann R, Quigley HA, Johnson GJ. The definition and classification of glaucoma in prevalence surveys. Br J Ophthalmol 2002; 86: 238-42.
6. Kroese M, Burton H. Primary open angle glaucoma. The need for a consensus case definition. J Epidemiol Community Health 2003; 57: 752-4.
7. Wilson MR. The myth of '21'. J Glaucoma 1997; 6: 75-7.
8. Collaborative Normal-Tension Glaucoma Study Group. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol 1998; 126: 487-97.
9. Heijl A, Leske MC, Bengtsson B, Hyman L, Hussein M. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 2002; 120: 1268-79.
10. Anderson DR, Drance SM, Schulzer M. Natural history of normal-tension glaucoma. Ophthalmology 2001; 108: 247-53.
11. Quigley HA, Addicks EM. Chronic experimental glaucoma in primates. I. Production of elevated intraocular pressure by anterior chamber injection of autologous ghost red blood cells. Invest Ophthalmol Vis Sci 1980; 19: 126-36.
12. Quigley HA, Guy J, Anderson DR. Blockade of rapid axonal transport. Effect of intraocular pressure elevation in primate optic nerve. Arch Ophthalmol 1979; 97: 525-31.
13. Crish SD, Sappington RM, Inman DM, Horner PJ, Calkins DJ. Distal axonopathy with structural persistence in glaucomatous neurodegeneration. Proc Natl Acad Sci U S A 2010; 107: 5196-201.
14. Chidlow G, Ebneter A, Wood JP, Casson RJ. The optic nerve head is the site of axonal transport disruption, axonal cytoskeleton damage and putative axonal regeneration failure in a rat model of glaucoma. Acta Neuropathol 2011; 121: 737-51.
15. Howell GR, Libby RT, Jakobs TC etal. Axons of retinal ganglion cells are insulted in the optic nerve early in DBA/2J glaucoma. J Cell Biol 2007; 179: 1523-37.
16. Leung CK, Weinreb RN, Li ZW etal. Long-term in vivo imaging and measurement of dendritic shrinkage of retinal ganglion cells. Invest Ophthalmol Vis Sci 2011; 52: 1539-47.
17. Weber AJ, Kaufman PL, Hubbard WC. Morphology of single ganglion cells in the glaucomatous primate retina. Invest Ophthalmol Vis Sci 1998; 39: 2304-20.
18. Kerrigan LA, Zack DJ, Quigley HA, Smith SD, Pease ME. TUNEL-positive ganglion cells in human primary open-angle glaucoma. Arch Ophthalmol 1997; 115: 1031-5.
19. Gupta N, Greenberg G, de Tilly LN, Gray B, Polemidiotis M, Yucel YH. Atrophy of the lateral geniculate nucleus in human glaucoma detected by magnetic resonance imaging. Br J Ophthalmol 2009; 93: 56-60.
20. Gupta N, Yucel YH. What changes can we expect in the brain of glaucoma patients? Surv Ophthalmol 2007; 52 (Suppl. 2): S122-6.
21. Gupta N, Yucel YH. Brain changes in glaucoma. Eur J Ophthalmol 2003; 13 (Suppl. 3): S32-5.
22. Fiedorowicz M, Dyda W, Rejdak R, Grieb P. Magnetic resonance in studies of glaucoma. Med Sci Monit 2011; 17: RA227-32.
23. Qing G, Zhang S, Wang B, Wang N. Functional MRI signal changes in primary visual cortex corresponding to the central normal visual field of patients with primary open-angle glaucoma. Invest Ophthalmol Vis Sci 2010; 51: 4627-34.
24. Gupta N, Ang LC, Noel de Tilly L, Bidaisee L, Yucel YH. Human glaucoma and neural degeneration in intracranial optic nerve, lateral geniculate nucleus, and visual cortex. Br J Ophthalmol 2006; 90: 674-8.
25. Hernandez MR. The optic nerve head in glaucoma: role of astrocytes in tissue remodeling. Prog Retin Eye Res 2000; 19: 297-321.
26. Hernandez MR, Pena JD. The optic nerve head in glaucomatous optic neuropathy. Arch Ophthalmol 1997; 115: 389-95.
27. Morgan JE. Optic nerve head structure in glaucoma: astrocytes as mediators of axonal damage. Eye (Lond) 2000; 14 (Pt 3B): 437-44.
28. Bosco A, Inman DM, Steele MR etal. Reduced retina microglial activation and improved optic nerve integrity with minocycline treatment in the DBA/2J mouse model of glaucoma. Invest Ophthalmol Vis Sci 2008; 49: 1437-46.
29. Ebneter A, Casson RJ, Wood JP, Chidlow G. Microglial activation in the visual pathway in experimental glaucoma: spatiotemporal characterization and correlation with axonal injury. Invest Ophthalmol Vis Sci 2010; 51: 6448-60.
30. Neufeld AH. Microglia in the optic nerve head and the region of parapapillary chorioretinal atrophy in glaucoma. Arch Ophthalmol 1999; 117: 1050-6.
31. Yuan L, Neufeld AH. Activated microglia in the human glaucomatous optic nerve head. J Neurosci Res 2001; 64: 523-32.
32. Quigley HA, Hohman RM, Addicks EM, Massof RW, Green WR. Morphologic changes in the lamina cribrosa correlated with neural loss in open-angle glaucoma. Am J Ophthalmol 1983; 95: 673-91.
33. Lahav K, Levkovitch-Verbin H, Belkin M, Glovinsky Y, Polat U. Reduced mesopic and photopic foveal contrast sensitivity in glaucoma. Arch Ophthalmol 2011; 129: 16-22.
34. Stamper RL, Hsu-Winges C, Sopher M. Arden contrast sensitivity testing in glaucoma. Arch Ophthalmol 1982; 100: 947-50.
35. Greenfield DS. Glaucomatous versus nonglaucomatous optic disc cupping: clinical differentiation. Semin Ophthalmol 1999; 14: 95-108.
36. Kong YX, Coote MA, O'Neill EC etal. Glaucomatous optic neuropathy evaluation project: a standardized internet system for assessing skills in optic disc examination. Clin Experiment Ophthalmol 2011; 39: 308-17.
37. Barkan O. Glaucoma: classification, causes, and surgical control. Results of microgonioscopic research. Am J Ophthalmol 1938; 2: 1099-114.
38. Drance S, Anderson DR, Schulzer M. Risk factors for progression of visual field abnormalities in normal-tension glaucoma. Am J Ophthalmol 2001; 131: 699-708.
39. Flammer J, Mozaffarieh M. What is the present pathogenetic concept of glaucomatous optic neuropathy? Surv Ophthalmol 2007; 52 (Suppl. 2): S162-73.
40. Aung T, Looi AL, Chew PT. The visual field following acute primary angle closure. Acta Ophthalmol Scand 2001; 79: 298-300.
41. Douglas GR, Drance SM, Schulzer M. The visual field and nerve head in angle-closure glaucoma. A comparison of the effects of acute and chronic angle closure. Arch Ophthalmol 1975; 93: 409-11.
42. Radius RL, Maumenee AE. Visual field changes following acute elevation of intraocular pressure. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol 1977; 83: 61-8.
43. Weinreb RN, Lindsey JD. The importance of models in glaucoma research. J Glaucoma 2005; 14: 302-4.
44. Brooks DE. Glaucoma in the dog and cat. Vet Clin North Am Small Anim Pract 1990; 20: 775-97.
45. Wilkie DA. Equine glaucoma: state of the art. Equine Vet J Suppl 2010; 42 (Suppl. 37): 62-8.
46. Gelatt KN, Gum GG, Gwin RM, Bromberg NM, Merideth RE, Samuelson DA. Primary open angle glaucoma: inherited primary open angle glaucoma in the beagle. Am J Pathol 1981; 102: 292-5.
47. Brooks DE, Strubbe DT, Kubilis PS, MacKay EO, Samuelson DA, Gelatt KN. Histomorphometry of the optic nerves of normal dogs and dogs with hereditary glaucoma. Exp Eye Res 1995; 60: 71-89.
48. Gaasterland D, Tanishima T, Kuwabara T. Axoplasmic flow during chronic experimental glaucoma. 1. Light and electron microscopic studies of the monkey optic nervehead during development of glaucomatous cupping. Invest Ophthalmol Vis Sci 1978; 17: 838-46.
49. Gaasterland D, Kupfer C. Experimental glaucoma in the rhesus monkey. Invest Ophthalmol 1974; 13: 455-7.
50. Shareef SR, Garcia-Valenzuela E, Salierno A, Walsh J, Sharma SC. Chronic ocular hypertension following episcleral venous occlusion in rats. Exp Eye Res 1995; 61: 379-82.
51. Levkovitch-Verbin H, Quigley HA, Martin KR, Valenta D, Baumrind LA, Pease ME. Translimbal laser photocoagulation to the trabecular meshwork as a model of glaucoma in rats. Invest Ophthalmol Vis Sci 2002; 43: 402-10.
52. Ueda J, Sawaguchi S, Hanyu T etal. Experimental glaucoma model in the rat induced by laser trabecular photocoagulation after an intracameral injection of India ink. Jpn J Ophthalmol 1998; 42: 337-44.
53. Morrison JC, Moore CG, Deppmeier LM, Gold BG, Meshul CK, Johnson EC. A rat model of chronic pressure-induced optic nerve damage. Exp Eye Res 1997; 64: 85-96.
54. Grozdanic SD, Betts DM, Sakaguchi DS, Allbaugh RA, Kwon YH, Kardon RH. Laser-induced mouse model of chronic ocular hypertension. Invest Ophthalmol Vis Sci 2003; 44: 4337-46.
55. Ji J, Chang P, Pennesi ME etal. Effects of elevated intraocular pressure on mouse retinal ganglion cells. Vision Res 2005; 45: 169-79.
56. Aihara M, Lindsey JD, Weinreb RN. Experimental mouse ocular hypertension: establishment of the model. Invest Ophthalmol Vis Sci 2003; 44: 4314-20.
57. Johnson TV, Tomarev SI. Rodent models of glaucoma. Brain Res Bull 2010; 81: 349-58.
58. John SW, Smith RS, Savinova OV etal. Essential iris atrophy, pigment dispersion, and glaucoma in DBA/2J mice. Invest Ophthalmol Vis Sci 1998; 39: 951-62.
59. Schuettauf F, Rejdak R, Walski M etal. Retinal neurodegeneration in the DBA/2J mouse - a model for ocular hypertension. Acta Neuropathol 2004; 107: 352-8.
60. Chauhan BC, Pan J, Archibald ML, LeVatte TL, Kelly ME, Tremblay F. Effect of intraocular pressure on optic disc topography, electroretinography, and axonal loss in a chronic pressure-induced rat model of optic nerve damage. Invest Ophthalmol Vis Sci 2002; 43: 2969-76.
61. Cohan BE, Pearch AC, Jokelainen PT, Bohr DF. Optic disc imaging in conscious rats and mice. Invest Ophthalmol Vis Sci 2003; 44: 160-3.
62. Neufeld AH, Sawada A, Becker B. Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma. Proc Natl Acad Sci U S A 1999; 96: 9944-8.
63. Cioffi GA, Sullivan P. The effect of chronic ischemia on the primate optic nerve. Eur J Ophthalmol 1999; 9 (Suppl. 1): S34-6.
64. Orgul S, Cioffi GA, Wilson DJ, Bacon DR, Van Buskirk EM. An endothelin-1 induced model of optic nerve ischemia in the rabbit. Invest Ophthalmol Vis Sci 1996; 37: 1860-9.
65. Quigley HA, Hohman RM. Laser energy levels for trabecular meshwork damage in the primate eye. Invest Ophthalmol Vis Sci 1983; 24: 1305-7.